{"cluster": 50, "subcluster": 69, "abstract_summ": "We saw what happened in China and watched the coronavirus spread through countries, but we were slow in reacting.\u2022 Coronavirus disease 2019 (COVID-19) is emerging and requires early diagnostics.In this Perspective, we discuss the utility and challenges of current diagnostics for COVID-19.The successful sequencing of the novel coronavirus SARS-CoV-2 nucleic acid paved the way for exploration of omics systems science and integrative biology research approaches for combating this unprecedented planetary health challenge.The coronavirus disease 2019 (COVID-19) pandemic has highlighted the need for different types of diagnostics, comparative validation of new tests, faster approval by federal agencies, and rapid production of test kits to meet global demands.This cohort study investigates how the coronavirus disease 2019 (COVID-19) pandemic is associated with national enrollment in cancer clinical trials.To the Editor The Coronavirus disease 2019 (COVID-19) has been declared as a pandemic by World Health Organisation (WHO).", "title_summ": "International expansion of a novel SARS-CoV-2 mutantCoronavirus Disease 2019 (COVID-19): Protecting Hospitals From the InvisibleTransforming a research institute into a COVID diagnostic centre \u2013 scientists step forward to protect public health during the coronavirus pandemicOptical techniques for fast screening \u2013 towards prevention of the coronavirus COVID-19 outbreakCOVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanismsAssociation of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical TrialsMeeting the challenge of the 2019 novel coronavirus disease in patients with cancerComment on \u201cGenetic variants and source of introduction of SARS\u2010CoV\u20102 in South America\u201dCoronavirus disease 2019: new things to know!Ratcheting down the virulence of SARS\u2010CoV\u20102 in the COVID\u201019 pandemicThe spread of the COVID\u201019 coronavirus: Health agencies worldwide prepare for the seemingly inevitability of the COVID\u201019 coronavirus becoming endemicMaking sense of mutation: what D614G means for the COVID-19 pandemic remains unclearHISTORICAL CORONA NAME IN DERMATOLOGY.COVID-19 diagnostics in context.COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research.Chloroquine in COVID-19: the evidence.", "title_abstract_phrases": "Optical techniques for fast screening \u2013 towards prevention of the coronavirus COVID-19 outbreak\u2022 Coronavirus disease 2019 (COVID-19) is emerging and requires early diagnostics.Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical TrialsThis cohort study investigates how the coronavirus disease 2019 (COVID-19) pandemic is associated with national enrollment in cancer clinical trials.Meeting the challenge of the 2019 novel coronavirus disease in patients with cancerThe alarming situation of the 2019 novel coronavirus disease (COVID\u201019) is contrasted by the limited efforts to curb the spread and impact of the disease among patients with cancer.Here we report that a novel SARS-CoV-2 mutation (ORF3a) appears to be spreading worldwide, which deserves close attention.The successful sequencing of the novel coronavirus SARS-CoV-2 nucleic acid paved the way for exploration of omics systems science and integrative biology research approaches for combating this unprecedented planetary health challenge."}